Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes
NCT06357000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3621
Last updated 2024-04-10
Summary
To evaluate the association between time from PCI to cancer surgery and cardiovascular and oncologic outcomes in early-stage cancer patients, A retrospective, population-based cohort study was conducted using data from the Korean National Health Insurance Service (K-NHIS) database.
Conditions
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-01
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
More Related Trials
-
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer
NCT05679583 ·Status: RECRUITING ·Phase: PHASE2
-
Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
NCT00506623 ·Status: UNKNOWN ·Phase: PHASE2
-
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
NCT02810652 ·Status: COMPLETED ·Phase: NA
-
GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery
NCT03471494 ·Status: COMPLETED
-
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
NCT01923987 ·Status: UNKNOWN ·Phase: PHASE2
-
Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea
NCT05587387 ·Status: UNKNOWN
-
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer
NCT03923309 ·Status: COMPLETED
-
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
NCT06758830 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
NCT04363983 ·Status: RECRUITING ·Phase: NA
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors
NCT06185907 ·Status: COMPLETED
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab
NCT02029326 ·Status: COMPLETED
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
Efficacy Study of Robotic Surgery for Rectal Cancer
NCT01591798 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Fitness After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
NCT01334593 ·Status: COMPLETED
-
Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study
NCT03546127 ·Status: COMPLETED
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Organ Preservation Surgery
NCT01330056 ·Status: COMPLETED ·Phase: NA
-
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
NCT03794193 ·Status: UNKNOWN
-
Short-course Preoperative Chemoradiotherapy for Rectal Cancer
NCT01431599 ·Status: UNKNOWN ·Phase: PHASE2
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment
NCT01932047 ·Status: UNKNOWN
-
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
NCT01781403 ·Status: COMPLETED ·Phase: PHASE1
-
Recurrence and Prognosis Prediction Model for Gastric Cancer
NCT07243847 ·Status: COMPLETED